.

Sanofi And GSK Launch Trial For COVID-19 Protein-Based Vaccine

French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the...

from NDTV News - World-news https://ift.tt/31PUQxM

Resent New

Discord abandons Microsoft acquisition talks: Report

Discussion platform Discord, popular among amateur video game players, has halted acquisition talks with Microsoft and is instead considerin...

Most popular News